Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cohort Study to Evaluate the Long-term Safety and Immunogenicity of the Candidate Ebola Vaccines Ad26.ZEBOV and MVA-BN®-Filo in Adults and Children

NCT03820739 is registered in ClinicalTrials.gov with London School of Hygiene and Tropical Medicine as lead sponsor.

NCT NCT03820739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03820739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cohort Study to Evaluate the Long-term Safety and Immunogenicity of the Candidate Ebola Vaccines Ad26.ZEBOV and MVA-BN®-Filo in Adults and Children
Lead sponsor
London School of Hygiene and Tropical Medicine
Phase
Observational
Overall status
Completed
Start date
July 22, 2019
Completion date
July 14, 2022
Enrollment
653 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ebola virus disease